Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML
暂无分享，去创建一个
B. Falini | L. Brunetti | C. Quintarelli | A. Marra | Y. Landesman | S. Shacham | P. Sportoletti | M. Martelli | B. Bigerna | S. Caruso | G. Pianigiani | Federica Mezzasoma | F. Rocchio | A. Gagliardi | F. Locatelli | G. Spinozzi | V. Tini